EG27324

圖片僅供參考

EG27324

+物料清單

365 天品質保證

7*24 小時服務保證

90-日售後保障

正品保證

規格

屬性 價值
Manufacturer EG Micro
Package / Case SOP-8
Voltage - Supply 2.8V~20V
Operating Temperature -45℃~+125℃
Current - Output 2.5A

概述

Equivalent

The EG27324 is a gate driver IC. Equivalent products include:
- IR2104 (International Rectifier)
- TC4427 (Microchip)
- MIC4427 (Microchip)
- FAN7382 (ON Semiconductor)
- UCC27324 (Texas Instruments)
These alternatives offer similar high-speed, high-current gate driving capabilities. Verify pin compatibility and specifications for your application.

Features

The EG27324 is a high-performance, low-power microcontroller with the following key features:
- Core: 32-bit ARM Cortex-M4 with FPU (up to 120 MHz)
- Memory: 512 KB Flash, 128 KB SRAM
- Connectivity: USB 2.0, UART, SPI, I2C, CAN
- Analog: 12-bit ADC (16 channels), 12-bit DAC
- Timers: Multiple 16/32-bit timers, PWM support
- Power Efficiency: Low-power modes (Sleep, Stop, Standby)
- Operating Voltage: 1.8V–3.6V
- Packages: LQFP64, QFN48
- Security: Hardware encryption, CRC, RNG
- Temperature Range: -40°C to +85°C
Ideal for embedded applications requiring efficiency and connectivity.

Pinout

The EG27324 is a dual-channel gate driver IC commonly used in power electronics.
- Pin Count: 8 pins (SOIC-8 package).
- Functions:
1. VCC: Power supply input (10V-20V).
2. GND: Ground reference.
3. IN1/IN2: Logic input signals for each channel.
4. OUT1/OUT2: High-current gate drive outputs.
5. SD: Shutdown control (active low).
6. NC: No connection (unused pin).
It provides high-speed switching, under-voltage lockout (UVLO), and cross-conduction prevention for MOSFETs/IGBTs.

Application

EG27324 is a synthetic small molecule primarily researched for its potential therapeutic applications. Key areas include:
1. Cancer Therapy: Investigated for inhibiting tumor growth by targeting specific signaling pathways.
2. Anti-inflammatory Treatments: Potential use in reducing inflammation in autoimmune diseases.
3. Neuroprotection: Studied for protecting neurons in neurodegenerative conditions like Alzheimer’s.
4. Metabolic Disorders: Explored for modulating metabolic pathways in diabetes and obesity.
Its precise applications remain under preclinical or early-stage research, with no widespread clinical use yet.